org placeholder image

Christopher

Director, Program and Alliance Management at Oncternal Therapeutics

  • LinkedIn

Email Email: c****@bmrn.com

phone noPhone Number: (***)-***-****

map
ONCTERNAL THERAPEUTICS

ONCTERNAL THERAPEUTICS

  • description Description
    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on pro...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 1 Million to 5 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Oncternal Therapeutics Org Chart and Mapping

Employees

Pablo Urbaneja

Senior Vice President, Corporate Development

Christopher -

Director, Program and Alliance Management

Sharon Yavrom

Sr. Director, Clinical Science

April May

Senior Director, Finance

Chase Leavitt

General Counsel & Corporate Secretary

Frequently Asked Questions Regarding Christopher -

Answer: Christopher works for Oncternal Therapeutics as Director, Program and Alliance Management

Answer: Christopher ’s role in Oncternal Therapeutics is Director, Program and Alliance Management

Answer: Christopher 's email address is c***@gmail.com

Answer: Christopher 's business email address is c****@bmrn.com

Answer: Christopher ’s direct phone number is (***)-***-****

Answer: Christopher works in the industry of: Biotechnology

Answer: Christopher works Oncternal Therapeutics located at El Camino Real Ste 300, San Diego, , 92130, California, 12230, United States

Answer: Oncternal Therapeutics's Director, Program and Alliance Management is Christopher

Answer: Christopher - contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@bmrn.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access